Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 8/20 | 0.56 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.51 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.51 |
| ▸ | CTSK | P43235 | 4/20 | 0.48 |
| ▸ | MME | P08473 | 1/20 | 0.48 |
| ▸ | ANPEP | P15144 | 1/20 | 0.48 |
| ▸ | CTSB | P07858 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29386568 | 0.95 | PTPN1 (0.57) | PTPN1HDAC1HDAC2CTSKMME | |
| SCHEMBL29384584 | 0.90 | PTPN1 (0.54) | PTPN1 | |
| SCHEMBL30690827 | 0.90 | HDAC1 (0.60) | HDAC1HDAC2MMEANPEP | |
| SCHEMBL9449847 | 0.89 | CTSK (0.57) | PTPN1HDAC1HDAC2CTSKCTSB | |
| SCHEMBL13154988 | 0.87 | PTPN1 (0.51) | PTPN1 | |
| SCHEMBL29480470 | 0.84 | CTSK (0.57) | PTPN1CTSKCTSB | |
| SCHEMBL15505343 | 0.84 | FDFT1 (0.48) | PTPN1 | |
| SCHEMBL13154758 | 0.83 | CTSK (0.60) | CTSKCTSB | |
| SCHEMBL12214455 | 0.83 | PTPN1 (0.52) | PTPN1HDAC1HDAC2 | |
| SCHEMBL21467220 | 0.83 | CTSK (0.57) | CTSKMMEANPEPCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220047698-A1 | SYNTHETIC INNATE IMMUNE RECEPTOR LIGANDS AND USES THEREOF | ALBERTA RES CHEMICALS INC (CA) | 2022-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220047698-A1 | SYNTHETIC INNATE IMMUNE RECEPTOR LIGANDS AND USES THEREOF | TLR3, TLR4, TLR9 | PTPN1 234/4885HDAC1 4288/4885HDAC2 4733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.